Detailseite
Projekt Druckansicht

Rolle der von Thrombozyten freigesetzten Calpaine bei der Diabetes-assoziierten Vaskulären Erkrankungen

Fachliche Zuordnung Anatomie und Physiologie
Förderung Förderung von 2013 bis 2020
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 250828505
 
Erstellungsjahr 2020

Zusammenfassung der Projektergebnisse

The initial goal of this project was to understand the role of extracellular/platelet-derived calpains in diabetes-associated vascular complications. The first funding period focused on three aims: 1. the identification of new calpain substrates on the surface of endothelial cells, 2. the characterization of the role of extracellular calpain in vascular reactivity and inflammation and 3. the investigation of the role of extracellular calpain in angiogenesis and vascular repair. We could successfully clarifiy aims 1 and 2 but did not manage to assess aim 3. We could show that calpain 1 carried by platelet-derived microparticles (PMPs) is largely involved in the alteration of vascular integrity and the increased vascular inflammation in diabetes by targeting the glycocalyx and the PAR-1 receptor on the endothelial cells. PAR-1 cleavage initiated intracellular signaling cascade leading to vascular inflammation in diabetes. Given that diabetes-associated vascular complications involve a complex interplay between the vascular wall and circulating cells, the aim of the second funding period was to analyze the effect of extracellular calpain 1 on circulating cells such as monocytes and neutrophils. Due to the difficulty collecting enough samples from diabetic patients, samples from women with polycystic ovary syndrome (PCOS) were investigated during the second funding period. Although deviating from the initial plan, these studies led to interesting new findings. We could show that in addition to expressing active calpain, platelets from PCOS patients demonstrate enhanced arginase levels and activity. We demonstrated that increased levels of arginasebearing PMPs contribute to the alteration of the arginine metabolism in patients with PCOS. Further investigation of platelets from PCOS led us to the finding that platelets are a source of collagen I and that levels were significantly enhanced in PCOS. In addition, we have identified Cyclin Y to be expressed in platelets and we have characterized its role in platelets. In summary, this project resulted in several important findings that clarify the molecular mechanisms of vascular complications associated to diabetes. We have identified new calpain substrates on the vascular wall as well as new proteins expressed by platelets.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung